to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Venture capital investing in health IT is expected to increase, while investing in medical devices and biopharmaceuticals drops, according to a recent National Venture Capital Association survey. Read more about why VCs are favoring health IT companies.
Life science startups looking for funding should keep foundations in mind as a potential source. Read more for tips on getting funding from foundations.
Would you, the healthcare startup owner, accept $50,000 in funding in exchange for a 7 percent equity stake in your business? That's the question a Chicago-based healthcare seed accelerator is asking healthcare entrepreneurs. And pretty soon, we'll see how they answer that question.
New healthcare businesses in some medical cities may benefit from the Occupy Wall Street movement. Read more about how cities in areas without state incentives for investment could be better off in the near future.
Life sciences startups seeking federal funding can benefit from these quick tips. Read more for ideas on where to look and how to go about it.
This glossary of terms should serve as a resource for helping you better understand many of the terms you will see and hear used as you launch your company. The terms are arranged alphabetically.
Local investing could be the answer to the problem of dealing with big banks and the way they do business. Read more about this funding alternative for startups.
Angel investors in the life sciences talk about when, why and how to seek angel funding for your pharmaceutical, mobile and medical device startups.
How do medical device startups and other new healthcare businesses get investments? They need to know how to answer some key questions, according to the manager of the West Health Investment Fund.
Small biotech companies may have the feeling that venture capital firms are avoiding small life sciences firms like the plague. But maybe not for long -- if Washington has anything to say about it.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.